Holders — by stockHoldings — by fund
TANG CAPITAL MANAGEMENT LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001232621
$2.20B
disclosed book value
41
positions
10.1%
largest position share
Positions, as of 2026-06-30
top 41 of 41 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | AUPHAURINIA PHARMACEUTICALS INC | 13.0M | $221.4M | 10.1% |
| 2 | SYRESPYRE THERAPEUTICS INC | 1.9M | $168.0M | 7.6% |
| 3 | MIRMMIRUM PHARMACEUTICALS INC | 1.2M | $144.7M | 6.6% |
| 4 | KINIKSA PHARMACEUTICALS INTL | 2.3M | $144.5M | 6.6% |
| 5 | CELCCELCUITY INC | 1.3M | $137.5M | 6.2% |
| 6 | CORTCORCEPT THERAPEUTICS INC | 1.5M | $130.4M | 5.9% |
| 7 | PTCTPTC THERAPEUTICS INC | 1.5M | $122.4M | 5.6% |
| 8 | LKFTLAKEFRONT BIOTHERAPEUTICS NV | 3.8M | $113.5M | 5.2% |
| 9 | CAPRCAPRICOR THERAPEUTICS INC | 4.1M | $98.7M | 4.5% |
| 10 | TARSTARSUS PHARMACEUTICALS INC | 1.6M | $98.7M | 4.5% |
| 11 | SPYSTATE STR SPDR S&P 500 ETF T | 123,000 | $91.9M | 4.2% |
| 12 | ANABANAPTYSBIO INC | 1.3M | $89.8M | 4.1% |
| 13 | IMCRIMMUNOCORE HLDGS PLC | 2.6M | $84.1M | 3.8% |
| 14 | CMPSCOMPASS PATHWAYS PLC | 5.0M | $70.8M | 3.2% |
| 15 | ANIPANI PHARMACEUTICALS INC | 707,500 | $58.6M | 2.7% |
| 16 | BNTXBIONTECH SE | 470,000 | $43.7M | 2% |
| 17 | CMPXCOMPASS THERAPEUTICS INC | 18.0M | $39.4M | 1.8% |
| 18 | PGENPRECIGEN INC | 6.4M | $36.6M | 1.7% |
| 19 | VRDNVIRIDIAN THERAPEUTICS INC | 1.8M | $32.9M | 1.5% |
| 20 | NVCTNUVECTIS PHARMA INC | 1.6M | $28.5M | 1.3% |
| 21 | DNTHDIANTHUS THERAPEUTICS INC | 264,692 | $25.8M | 1.2% |
| 22 | FULCFULCRUM THERAPEUTICS INC | 6.5M | $23.9M | 1.1% |
| 23 | AVIRATEA PHARMACEUTICALS INC | 4.8M | $22.4M | 1% |
| 24 | CRESCENT BIOPHARMA INC. | 1.2M | $20.9M | 0.9% |
| 25 | NNDMNANO DIMENSION LTD | 14.3M | $20.7M | 0.9% |
| 26 | VKTXVIKING THERAPEUTICS INC | 500,000 | $19.5M | 0.9% |
| 27 | NUVBNUVATION BIO INC | 3.3M | $18.7M | 0.9% |
| 28 | IDYAIDEAYA BIOSCIENCES INC | 450,000 | $16.8M | 0.8% |
| 29 | GOSS 5 06/01/27GOSSAMER BIO INC | 17.8M | $11.5M | 0.5% |
| 30 | DERMJOURNEY MED CORP | 1.6M | $11.4M | 0.5% |
| 31 | INSMINSMED INC | 100,000 | $10.7M | 0.5% |
| 32 | STOKSTOKE THERAPEUTICS INC | 300,000 | $9.8M | 0.4% |
| 33 | PLRXPLIANT THERAPEUTICS INC | 6.1M | $7.0M | 0.3% |
| 34 | BOLDBOUNDLESS BIO INC | 2.6M | $6.4M | 0.3% |
| 35 | PMVPPMV PHARMACEUTICALS INC | 4.2M | $5.7M | 0.3% |
| 36 | MRNAMODERNA INC | 50,000 | $3.5M | 0.2% |
| 37 | WAVE LIFE SCIENCES LTD | 600,000 | $3.5M | 0.2% |
| 38 | HRTXHERON THERAPEUTICS INC | 6.3M | $2.7M | 0.1% |
| 39 | LENZLENZ THERAPEUTICS INC | 451,114 | $2.6M | 0.1% |
| 40 | ALTALTIMMUNE INC | 666,022 | $2.0M | 0.1% |
| 41 | RCKTROCKET PHARMACEUTICALS INC | 100,000 | $342,000 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.